Predictors of Hepatic Decompensation during Ombitasvir/Paritaprevir/Ritonavir ± Dasabuvir ± Ribavirin Treatment of Genotype 1 and 4 HCV Infected Patients (Real Life Amber Study)
Flisiak, R., Jaroszewicz, J., Janczewska, E., Wawrzynowicz-Syczewska, M., Grabinska, A., Bolewska, B., Pisula, A., Karpinska, E., Mozer-Lisewska, I., Madej, G.Volume:
64
Year:
2016
Language:
english
Journal:
Journal of Hepatology
DOI:
10.1016/s0168-8278(16)01593-2
File:
PDF, 50 KB
english, 2016